new cases diagnosed each year (11) . As a permanent cure from IBD is still not possible, most patients require constant medication and/or surgery to keep the disease in remission (11) . One of the few therapeutic options is targeting of TNF-␣, because it plays a role in causing damage in the GI tract through its proinflammatory responses. However, TNF-␣ is required for protection of the mucosa against noxious stimuli (49, 66) , which makes constant blockage of this cytokine deleterious for long-term therapy (12) . Indeed, anti-TNF-␣ therapy increases the risk of infection and lymphoma (9, 42, 43) . Thus, because current therapeutic strategies are risky or ineffective for long-term use, new therapies or methods for prevention of IBD remain a priority for reducing disease burden in North America.
Because of their antimicrobial (10, 48) , anti-inflammatory (29, 63) , and antiallergy (38) properties, lavender (Lavandula spp.) essential oils (LEO) have been used for centuries to treat numerous ailments, including acute and chronic intestinal symptoms (10, 15, 26, 27) . The therapeutic strength of LEO is determined by the properties of the constituents of LEO, primarily the monoterpenes, such as 1,8-cineole, borneol, and linalool/linalyl acetate, which are anti-inflammatory in nature (33, 53, 57) . While these constituents have been studied and shown to have beneficial properties in isolation, their synergistic effects on colitis have not been determined. We have produced a novel lavender cultivar, Lavandula ϫ intermedia cultivar Okanagan lavender, which produces a unique blend of essential oil [Okanagan LEO (OLEO)] enriched with two of the major therapeutic components: 1,8-cineole and borneol (14) . We tested the efficacy of OLEO in a murine model of acute colitis.
A robust and commonly used model of acute colitis, appropriate for investigations of bacteria-induced inflammation, exploits the attaching/effacing murine bacterial pathogen Citrobacter rodentium. C. rodentium is used to model infections by the human-specific enteric bacterial pathogens, enteropathogenic Escherichia coli and enterohemorrhagic E. coli. C. rodentium infects the apical region of the colonic epithelium of mice, interacting directly with the innate immune system, and is characterized by T helper type 1 (Th1) and type 17 (Th17) responses with neutrophil and macrophage infiltration, crypt cell hyperplasia, mucodepletion, and barrier disruption, resulting in acute colitis (6, 21-24, 37, 40) . Recently, we demonstrated that the composition of the enteric microbiota affects susceptibility to C. rodentium-induced colitis (20) . In this study, we examined the effect of OLEO on the enteric microbiota and intestinal immune responses during C. rodentiuminduced colitis. We found that, in colitic mice orally gavaged with OLEO, disease was less severe: morbidity and mortality were decreased, intestinal tissue damage was reduced, infiltra-tion of neutrophils and macrophages was decreased, levels of cytokines, chemokines, and inflammatory mediators were reduced, and levels of regulatory T cell populations were increased compared with untreated colitic mice. We show that oral administration of OLEO induced microbiota enriched with members of the phylum Firmicutes, including segmented filamentous bacteria (SFB), which are known to protect against C. rodentium-induced colitis. Additionally, during infection, OLEO treatment promoted the maintenance of microbiota loads with enriched Firmicutes populations closely associated with the gut cell wall, which corresponded with less systemic pathogen translocation measured in vivo. OLEO helped control pathogen load through inhibition of C. rodentium growth shown via microbial growth assays, primarily through the effects of 1,8-cineole, and decreased adherence to intestinal epithelial cells shown with Caco-2 cell cultures, primarily through the effects of 1,8-cineole and borneol. These results suggest that OLEO decreases damaging intestinal inflammatory responses through procommensal and antipathogen mechanisms and may be a potential therapeutic agent for colonic inflammation. These findings reveal that a pharmacological agent such as OLEO can alter enteric microflora, which can affect enteric disease susceptibility.
MATERIALS AND METHODS
LEO and purified constituents. Wild-type Lavandula ϫ intermedia was used to develop OLEO by somatic mutagenesis, as previously reported (14) . The essential oil was extracted from the wild-type (LEO) or the mutant (OLEO) by steam distillation using a modified Likens-Nickerson-type apparatus. Briefly, 500 g of flowers were boiled in deionized water for 45 min, and the vaporized essential oil constituents were condensed using a standard water-cooled condenser into a round-bottom flask. Essential oil samples were kept in dark glass bottles at 4°C until they were used as a 1 mg/ml solution. Essential oil composition was established by gas chromatographymass spectrophotometry, as described previously (14) and reported in Table 1 . The purified constituents 1,8-cineole (catalog no. C80601, Sigma), camphor (catalog no. RA10260, Fluka), and borneol (catalog no. 13580, Fluka) were stored in dark glass bottles at 4°C until they were used as 1 M solutions.
Mice. Six-to 8-wk-old C57BL/6 and C3H/HeOuJ mice (Jackson Laboratories, Bar Harbor, ME) were maintained in sterilized, filtertopped cages, handled in tissue culture hoods, and fed autoclaved food and water under specific pathogen-free conditions in animal facilities at the Child and Family Research Institute (Vancouver, BC, Canada). Sentinel animals were routinely tested for common pathogens. The protocols were approved by the University of British Columbia Animal Care Committee and were carried out in direct accordance with guidelines drafted by the Canadian Council on the Use of Laboratory Animals.
Bacterial strains, infection of mice, and OLEO treatment. Mice were infected by oral gavage using ϳ2.5 ϫ 10 8 colony-forming units (cfu) of C. rodentium DBS100 wild-type for 5-10 days. Using a modification of a procedure for oral administration of lavender oil extracts described elsewhere (5), we administered a 50 mg·kg Ϫ1 ·day Ϫ1 dose starting at 30 min postinfection and continued throughout the infection. In the absence of infection for microbial analysis in C57BL/6 mice, OLEO was gavaged at 50 mg·kg Ϫ1 ·day Ϫ1 for a total of 5 days. OLEO was diluted in mineral oil, or mineral oil was gavaged alone as the control group. Mice were euthanized at indicated time points throughout infection, and tissues were prepared for analysis.
Survival and body weight measurement. Mice were monitored for morbidity throughout the infection, and animals that showed terminal symptoms, such as dehydration and a hunched posture, along with limited movement, piloerection and shaking, and/or severe weight loss (Ͼ20% of preinfection body weight), were euthanized. Mice were weighed immediately prior to infection and at specified intervals until 10 days postinfection. Body weight data are presented as mean percentage of the starting weight of each mouse at each time point, whereas survival data are presented as percentage of the initial number of mice surviving at each time point.
Tissue collection and bacterial counts. Tissue collection and bacterial counts were performed as previously described (37) . Briefly, mice were euthanized over the course of infection and dissected, and the large intestine, including the cecum, was collected in 10% neutral buffered formalin (Fisher) for histological analysis or processed for tissue pathology assays. For viable cell counts, the spleen and mesenteric lymph nodes were collected from C3H/HeOuJ mice and homogenized in PBS (pH 7.4), with dilutions plated onto LuriaBertani (LB) agar plates.
Histopathological scoring. For assessment of tissue pathology, paraffin-embedded intestinal tissue sections (3 m) that had been stained with hematoxylin and eosin were examined by two blinded observers, and scores were averaged. Sections from six mice per group were assessed for submucosal edema (0 ϭ no change, 1 ϭ mild, 2 ϭ moderate, 3 ϭ profound), goblet cell depletion (on the basis of numbers of goblet cells per high-power field averaged from 5 fields at ϫ400 magnification: 0 ϭ Ͼ50, 1 ϭ 25-50, 2 ϭ 10 -25, 3 ϭ Ͻ10), epithelial hyperplasia (on the basis of percentage above the height of the control: 0 ϭ no change, 1 ϭ 1-50%, 2 ϭ 51-100%, 3 ϭ Ͼ100%), epithelial integrity (0 ϭ no change, 1 ϭ Ͻ10 epithelial cells shedding per lesion, 2 ϭ 11-20 epithelial cells shedding per lesion, 3 ϭ epithelial ulceration, 4 ϭ epithelial ulceration with severe crypt destruction), and white blood cell (WBC) infiltration (0 ϭ Ͻ5 WBCs/ high-power field, 1 ϭ 5-20 WBCs/high-power field, 2 ϭ 21-60 WBCs/high-power field, 3 ϭ 61-100 WBCs/high-power field, 4 ϭ Ͼ100 WBCs/high-power field). The maximum score that could result from this scoring was 17, with scores ranging between 6 and 8 reflecting typical responses to C. rodentium infection and scores Ͼ8 reflecting exaggerated tissue damage.
Immunofluorescence. Paraffin-embedded tissue sections were deparaffinized and rehydrated using standard techniques. For macrophage and neutrophil analysis, antigen retrieval of rehydrated tissues was performed using a 1-mg trypsin tablet (Sigma) dissolved in 1 ml of water for 20 -30 min at room temperature. The tissue was washed, and nonspecific sites were blocked with 5% BSA (Sigma) and then incubated with primary rat monoclonal antibody made against F4/80 for macrophages (Cedarlane Laboratories), rabbit polyclonal antibody made against myeloperoxidase for neutrophils (Neomarkers, Thermo Fisher), or rabbit polyclonal antibody made against FOXP3 (Santa Cruz Biotechnology) for regulatory T cells and then with secondary antibody [goat anti-rat labeled with Fluor 488 (green) or goat antirabbit IgG labeled with Dilyte Fluor 594 (red)]. Tissue sections were mounted with Prolong Gold Antifade reagent containing 4=,6=-diamidino-2-phenylindole (DAPI; Invitrogen) and visualized with a microscope (Nikon Eclipse E800) equipped with a digital camera (model DXM1200, Nikon) operating through Nikon ACT-1 version 2.20 software.
RNA and DNA extractions and quantitative real-time PCR. For RNA extractions, after the mice were euthanized, colonic tissues were immediately transferred to RNAlater (Qiagen) and stored at Ϫ20°C. Total RNA was purified using RNeasy kits (Qiagen) according to the manufacturer's instructions. cDNA was synthesized with the iScript cDNA synthesis kit (Bio-Rad) using 1 g of RNA. For DNA extractions, after the mice were euthanized, colonic tissues were homogenized, and the bacterial genomic DNA was extracted using a stool kit (Qiagen) according to the manufacturer's instructions. Quantification of DNA was performed on a Bio-Rad CFX Manager 2.0 machine using Sso Fast Eva Green Supermix (Bio-Rad). All quantitative PCRs (qPCRs) were performed in duplicate in a volume of 10 l with use of high-profile white tubes and ultraclear sealing tapes (Bio-Rad). With use of cDNA or 50 ng/l of bacterial DNA, PCR was conducted with cycling conditions of 95°C for 30 s and 39 cycles of 95°C for 5 s followed by 55-60°C for 5 s and, finally, 95°C for 10 s followed by a melt curve (from 65°C to 95°C in 0.5°C increments for 5 s). All primers were synthesized by Integrated DNA Technology. Primer efficiencies were verified according to the Minimum Information for Publication of Quantitative Real-Time PCR Experiments guidelines. GAPDH, inducible nitric oxide synthase (iNOS), TNF-␣, mouse macrophage inflammatory protein (MIP)-2␣, mouse mast cell protease-1, IFN-␥ (22, 37), IL-10 (1), and IL-22 (72) primers are described elsewhere. The specificity of bacterial primers (Table 2) was verified using the In Silico PCR database (http://insilico.ehu.es/) and the 16S rRNA database (http://rdp.cme.msu.edu/index.jsp). For SFB, we used National Center for Biotechnology Information primer blast tool against Candidatus arthomitus spp. SFB-mouse-Japan complete genome (GenBank accession no. AP012202.1) to design primers to amplify the region from 186099 to 186298 of the 16S rRNA gene. Expression of GAPDH was used as a reference for gene expression analysis, whereas relative values for bacterial groups were normalized to total bacteria present amplified using the eubacteria primer. Quantification of gene expression was carried out using CFX Manager software version 1.6.541.1028 (Bio-Rad) where PCR efficiencies for each of the primer sets were incorporated into the final calculations.
Fluorescent in situ hybridization and SYBR Green DNA staining. Fluorescent in situ hybridization (FISH) and SYBR Green analysis were performed as previously described (20, 41) . Briefly, colonic luminal contents were weighed, homogenized, and stored in 3.7% formalin at 4°C. For SYBR Green DNA staining, samples were filtered onto Anodisc 25 filters (Whatman International; 0.2 m pore size, 2.5 cm diameter). Each sample was completely dried and then stained with SYBR Green I nucleic acid gel stain (Invitrogen). For FISH, samples were filtered onto a polycarbonate membrane filter (Nucleopore Track-Etch Membrane, Whatman International), dehydrated, and incubated overnight at 37°C in hybridization solution (0.9 M NaCl, 0.1 M Tris, pH 7.2, 30% formamide, and 0.1% SDS) containing a combination of three Texas Red-conjugated probes covering several Firmicutes members (LGC354a: 5=-TGGAAGA-TTCCCTACTGC-3=; LGC354b: 5=CGGAAGATTCCCTACTGC 3=;
LGC354c: 5=CCGAAGATTCCCTACTGC 3=) (46, 54) , a Texas Redconjugated Bacteriodes probe (CFB286: 5=-TCCTCTCAGAAC-CCCTAC-3=), and a FITC-labeled ␥-Proteobacteria probe (GAM42a: 5=-GCCTTCCCACATCGTTT-3=), along with FITC or a Texas Redlabeled EUB probe (EUB338: 5=-GCTGCCTCCCGTAGGAGT-3=). Sequence specificity of CFB and GAM (69) , as well as EUB (2) and LGC (30) , probes was verified through the 16S rRNA database or the probeCheck database (http://131.130.66.200/cgi-bin/probecheck/ content.pl?idϭhome). After incubation, the filters were washed in hybridization solution and then in wash buffer (0.9 M NaCl and 0.1 M Tris, pH 7.2). Filters were dried and mounted on glass slides using ProLong Gold Antifade (Invitrogen) and viewed as described above; four to six fields per disk were randomly chosen, and the number of cells was counted and averaged. Total microbiota load was calculated by averaging the number of SYBR Green-positive cells per gram of tissue weight accounting for total filter area of 2.01 cm 2 , picture dimensions of 5.622 ϫ 10 Ϫ2 , and ϫ100 objective magnification. Percentages of Firmicutes, Bacteroidetes, and ␥-Proteobacteria were calculated on the basis of the number of positively probed bacteria divided by the number of positive DAPI-stained bacterial nuclei and averaged over several fields of view. Similar to Bergstrom et al. (7), FISH was performed on tissue sections as follows: paraffin-embedded tissue sections were deparaffinized and rehydrated and then incubated overnight at 37°C in the dark with the LGC and EUB probes. Sections were washed with hybridization solution, wash buffer, and distilled H 2O and mounted and viewed as described above.
In vitro antimicrobial plate and culture assays. For plate assays, C. rodentium culture (100 l of 0.8 optical density) was used to inoculate LB agar by spread plating. Fisherbrand filter paper (qualitative P8, porosity: course, flow rate: fast) was cut into 8-to 10-mmdiameter disks, sterilized, and inoculated with 20 l of LEO, OLEO, mineral oil, 1,8-cineole, borneol, or camphor. Disks were placed in the center of the plates and incubated at 37°C for 18 h. Zones of inhibition were measured and averaged. For culture assays, Caco-2 cells (American Type Culture Collection) were grown at 37°C and 5% CO 2 in DMEM with 4.5 g/l D-glucose, 1ϫ nonessential amino acids, L-glutamine, penicillin (100 U/ml), streptomycin (100 g/ml), and 20% fetal bovine serum (Sigma). The cells were seeded at high density in polystyrene T25 (25-cm 2 ) culture flasks or 24-well plates and used for experiments after they achieved ϳ80% confluence. Wells were infected with C. rodentium at a multiplicity of infection of 30 for 4 h in the presence of OLEO, LEO, 1,8-cineole, borneol, camphor, or mineral oil, and adherence assays were performed as previously reported (36) . Briefly, cells were washed with warm DMEM three times and scraped into warm PBS and mixed by pipetting. Serial 
RESULTS
OLEO decreases mortality and morbidity during C. rodentium-induced colitis. Some studies have provided in vitro evidence for antimicrobial (10, 48) and anti-inflammatory (29, 63) properties of LEO, while other studies have reported that single components isolated from LEO are anticolitic in vivo (33, 57) . We have produced a novel cultivar of lavender high in two of the therapeutic monoterpenes, 1,8-cineole and borneol (Table 1 ) (14) . To determine if OLEO had therapeutic value against colitis, we tested its efficacy in a mouse model of C. rodentium-induced infectious colitis. As disease progression and prognosis in this model are highly dependent on the mouse strain, we tested two strains of mice. We orally gavaged C57BL/6 mice, which develop a self-resolving colitis with little infection-induced mortality, as well as highly susceptible C3H/HeOuJ mice, which suffer 100% infection-induced morbidity (67), with OLEO or mineral oil (vector only). We found that OLEO could protect against infection-induced morbidity and mortality in these mice (Fig. 1) . Infected C3H/HeOuJ mice orally gavaged with OLEO suffered modest levels of mortality, with one-third of the animals requiring euthanization by 9 days postinfection (Fig. 1A) , in contrast to infected mice gavaged with mineral oil, which exhibited 100% infection-induced mortality and required euthanization between 6 and 7 days postinfection. Body weight loss was significantly decreased in C. rodentium-infected C57BL/6 mice treated with OLEO compared with mineral oil alone (Fig. 1B) . This suggested that OLEO rescued susceptible C3H/HeOuJ mice from lethal colitis and reduced infection-associated morbidity in resistant C57BL/6 mice.
OLEO protects against severe cecal mucosal damage during C. rodentium infection. Normally, C57BL/6 mice endure moderate inflammation and intestinal pathology characterized by increased crypt height, WBC infiltration, goblet cell depletion, and disruption of epithelial integrity during C. rodentium infection (21) . C. rodentium starts colonization of the cecal tissues and is disseminated from the cecum to the distal colon, and cecal and distal colonic tissues are equally colonized and damaged (21) (22) (23) . To determine if OLEO could reduce the tissue damage associated with acute colitis, we examined the cecal and distal tissues of infected treated or infected control mice for assessment by histopathological scoring. As shown in Fig. 2 , the C57BL/6 mice orally gavaged with vector only (10 days postinfection) developed the above-described injuries in cecal tissues. In contrast, cecal tissue of the C57BL/6 mice orally gavaged with OLEO developed little to no damage and was similar to cecal tissue of the uninfected healthy mice. The averaged total scores for infected mice (9.01 and 2.98 for untreated and OLEO-treated mice, respectively) suggest that cecal damage due to intestinal inflammation caused by C. rodentium is decreased when mice are treated with OLEO. Unexpectedly, we found that the distal colon was similarly damaged in treated and control mice (data not shown), suggesting that OLEO had a specific effect in the cecum, but not the colon.
OLEO decreased C. rodentium-induced immune responses. C. rodentium-induced colitis is characterized by production of proinflammatory cytokines and chemokines (16) . To evaluate the effect of OLEO on the production of inflammatory mediators during C. rodentium-induced colitis, RNA extracted from cecal tissues of C57BL/6 mice was assessed by qPCR for the expression of genes known to be involved during infectioninduced inflammation. OLEO-treated mice express signifi- Fig. 1 . Lavandula ϫ intermedia cultivar Okanagan lavender essential oil (OLEO) reduces mortality and morbidity during Citrobacter rodentium infection. A: C. rodentium infection induced greater mortality in susceptible C3H/ HeOuJ mice orally gavaged with vector only (mineral oil) than in mice orally gavaged with OLEO. In 100% of the mice orally gavaged with mineral oil, euthanization was required between 6 and 7 days postinfection, whereas euthanization was required at 9 days postinfection in one-third of mice orally gavaged with OLEO, in each of 3 separate experiments. Results from 1 representative experiment are shown. Each point represents percentage of surviving mice from an initial population of 3 mice. B: body weights of resistant C57BL/6 mice orally gavaged with the vector or OLEO over the first 10 days of a C. rodentium infection. Values (means Ϯ SE) represent average weight data pooled from Ն6 mice. Body weight loss was significantly greater for C57BL/6 mice orally gavaged with mineral oil than for mice orally gavaged with OLEO at 10 days postinfection (pi): *P Ͻ 0.05. cantly reduced levels of iNOS, IFN-␥, IL-22, and MIP-2␣ mRNA compared with infected control mice (Fig. 3A) . No significant difference was seen in expression of IL-10 between the groups. Correspondingly, phagocytic cell infiltration was decreased in the OLEO-treated mice (Fig. 3B) . Immunofluorescent imaging showed decreased recruitment of macrophages and neutrophils in cecal tissues in C. rodentiuminfected mice treated with OLEO (Fig. 3B) . In contrast, many F4/80-positive macrophages and myeloperoxidasepositive neutrophils were recruited to the submucosa in infected C57BL/6 mice that were gavaged with vector only (10 days postinfection). To determine if regulatory T cell infiltration was also modulated with OLEO treatment during infection, we examined regulatory T cells via immunofluorescence using an antibody specific to FOXP3 (Fig. 4C) . We found that while C. rodentium infection inhibits the presence of infiltrating FOXP3 ϩ regulatory T cells, OLEO-treated mice maintained cecal FOXP3 ϩ regulatory T cells during infection at the level of uninfected mice. These results reveal that treatment with OLEO during acute colitis reduces damage-associated inflammation and maintains protective regulatory T cells.
OLEO modulates the enteric microbiota. The intestinal microflora is an important factor in the susceptibility of colitis (19, 20, 52) . We previously showed that strain-dependent variation in susceptibility to C. rodentium is regulated by the intestinal microflora (20) . To determine if OLEO modulated the ecology of the enteric microbiota, promoting resistance to acute colitis, we examined various bacterial groups previously implicated in gut health (Table 2) prior to infection in OLEOtreated and untreated mice. We orally gavaged C57BL/6 mice with OLEO or mineral oil (vector only) and excised cecal tissues, extracted bacterial DNA, and used specific primers to amplify relative levels of microbes via qPCR. Bacteroidetes and Firmicutes are the two predominating phyla in the gut; ␥-Proteobacteria is normally present at Ͻ5%. We found that OLEO modulated several Firmicutes enteric bacteria (Fig. 4) . SFB, Clostridia spp., and Eubacterium rectale were significantly increased in the ceca of OLEO-treated mice, whereas several other enteric microbes, including Bacillus spp., Lactobacillus spp., and the Clostridium coccoides group, were unchanged. Nor did we detect differences in the other dominant phyla in the gut, such as members of Bacteroidetes or Proteobacteria. Of particular importance, SFB have been shown to protect against C. rodentium-induced colitis (32) .
C. rodentium decreases the total microbial load, enriching ␥-Proteobacteria and decreasing members from the phylum Bacteroidetes (41) . To determine if OLEO treatment during C. rodentium infection maintained total bacterial loads and altered the major phyla of colonic bacteria, we used SYBR Green staining for total quantification and FISH, since Lupp et al. (41) reported that, during C. rodentium infection, differences between samples were significant at the phylum level. OLEO promoted the maintenance of the total microflora loads during infection (Fig. 5A) , and ␥-Proteobacteria levels were significantly lower in the OLEO-treated than the mineral oil control group (Fig. 5B) . While Bacteroidetes quantity was not different, the Firmicutes quantity was significantly greater in OLEO-treated than untreated infected mice (Fig. 5B) . Since several Firmicutes are considered protective (50) and we observed that OLEO treatment enriched several Firmicutes prior to infection (Fig. 4) , we examined their proximal relationship with the intestinal epithelium during infection (Fig. 5C ). We Fig. 2 . OLEO treatment reduces cecal tissue damage during C. rodentium infection. C57BL/6 mice orally gavaged with vector only (mineral oil) or OLEO were infected with C. rodentium and assessed for intestinal pathology at 10 days postinfection. A: representative micrographs show that cecal tissue isolated from infected mice orally gavaged with vector only were damaged, in contrast to cecal tissue isolated from infected mice orally gavaged with OLEO. Original magnification ϫ100; hematoxylin-eosin stain. B: histopathological scoring of epithelial integrity, white blood cell infiltration, submucosal edema, mucodepletion, and hyperplasia in cecal tissues from C57BL/6 mice orally gavaged with vector only or OLEO. Score for damage was significantly higher in cecal tissue from mice orally gavaged with vector only than from mice orally gavaged with OLEO. Values are means Ϯ SE from 6 mice. *P Ͻ 0.01 vs. day 10 pi.
observed an intimate association of Firmicutes with the apical region of the intestinal epithelial cells, suggesting that any protective effect was potentially through contact with the gut wall. This was different from untreated colitic mice, whose gut wall showed very little attachment of associated Firmicutes probe. This suggested that OLEO may selectively modulate the Firmicutes population and promote their association with the gut wall, outcompeting the ␥-Proteobacteria, most of which are presumably C. rodentium.
OLEO inhibits systemic infection of C. rodentium. To determine if enteric microflora alterations and reduced colitis were associated with decreased C. rodentium loads, we assessed bacterial loads in vivo in C3H/HeOuJ mice orally gavaged with mineral oil and in C3H/HeOuJ mice orally gavaged with OLEO. The spleen and mesenteric lymph nodes were removed from infected mice immediately following euthanization for homogenization and plating of the tissue homogenates to determine colony-forming units. The infected mice orally gavaged with OLEO showed decreased systemic C. rodentium (Fig. 6) . Bacterial translocation or systemic disease and total bacterial load are correlative in C. rodentium colitis (6, 7, 20 -24, 37, 67) . This is likely because C. rodentium is luminal and does not invade cells but, rather, attaches and effaces the intestinal epithelial cells, and when these cells are eroded, as in ulcers, the pathogen crosses, becomes systemic, and also proliferates, forming biofilm-like structures with greater logarithmic growth of bacteria in susceptible mice (21) . Since OLEO inhibited systemic disease, our results suggest that OLEO may interfere with C. rodentium adherence to the epithelium or growth.
OLEO inhibits adherence and growth of C. rodentium in vitro. To assess whether OLEO or the purified constituents of OLEO could prevent C. rodentium adherence, we used an in vitro assay similar to that used by Khan et al. (36) . Cultured ϩ regulatory T cells during C. rodentium infection at the level of uninfected mice. Cecal tissue from infected C57BL/6 mice orally gavaged with OLEO or vector only was stained for the presence of FOXP3 ϩ cells, DAPI was used to stain for host cell nuclei, and whole tissues pieces were quantified at ϫ100 magnification. C. rodentium infection resulted in significantly decreased levels of FOXP3 ϩ cells/ tissue, while OLEO treatment prevented this. *P Ͻ 0.05.
Caco-2 cells where infected with C. rodentium and also incubated with OLEO, LEO, and the individual constituents that are higher in OLEO and reported to have therapeutic activity (Table 1: borneol, and 1,8-cineole), as well as with camphor. The cells were infected with C. rodentium, and adherence was determined as previously described (36) . We found significantly less adherent C. rodentium in OLEO-than LEO-treated cells (Fig. 7A) . We found that 1,8-cineole and borneol, but not camphor, were important in blocking adherence, since C. rodentium adherence was significantly less (and similar to adherence in OLEO-treated cells) in cells treated with both of these purified constituents than in cells treated with mineral oil. Since it has been reported that C. rodentium does not bind Caco-2 cells (65), we also performed this assay using enteropathogenic E. coli, which is human-specific and binds Caco-2 cells, and found similar trends (data not shown). These results suggest that the primary constituents involved in protecting intestinal epithelial cells against pathogen adherence are 1,8-cineole and borneol, which are present in higher levels in OLEO than LEO (Table 1) .
To assess whether OLEO had antimicrobial activity against C. rodentium, plate-killing assays were carried out to determine the zones of inhibition. Plates inoculated with C. rodentium and treated with disks infused with OLEO showed a 24 Ϯ 0.7 mm diameter zone of inhibition (Fig. 7B ). For comparison, in disks infused with LEO, we found a statistically similar 22 Ϯ 1.2 mm diameter zone of inhibition, and we found that 1,8-cineole was the only constituent with antimicrobial activity. In isolation, however, 1,8-cineole was not as effective as the oil extracts, at 2.7-fold less inhibition. In contrast, plates treated with disks alone or disks infused with mineral oil, camphor, or borneol were completely overgrown with C. rodentium, showing no zone of inhibition. Using nutrient broth growth assays, we also found that OLEO inhibited the growth of C. rodentium (data not shown). These results suggest that a combination of constituents in OLEO synergistically produce the greatest antimicrobial activity.
DISCUSSION
Current treatment options to manage colitis include immunosuppressors, anti-TNF-␣ therapy, and corticosteroids. Because these treatment options have significant side effects, such as increased susceptibility to infection and cancer (28) , there is a need for safer and more effective treatment options. In this study, we examined OLEO for its potential protective effects during murine C. rodentium-induced colitis. Our study shows that oral gavage with OLEO results in an attenuated colitis, as confirmed by its effects on morbidity, mortality, histology, and inflammatory responses. The protective mechanism of OLEO treatment was associated with modulation of the enteric microflora, selectively increasing several Firmicutes members, such as SFB, and inhibition of C. rodentium growth and adherence to intestinal epithelial cells in vitro and systemic infection in vivo. This study reports that OLEO can protect against murine infectious colitis. If this holds true for humans ) for 5 days and euthanized, intestines were excised, and DNA was extracted for qPCR using specific primers to the 16S rRNA gene of bacterial species in the microbiota. Values were normalized to total bacteria present amplified using a Eubacterial probe. NA, not amplified. *P Ͻ 0.05; **P Ͻ 0.001.
as well, OLEO could be a potential therapeutic strategy against intestinal inflammation.
We recently showed that the microbiota play a critical role in disease susceptibility to acute infectious colitis (20) . In this study, we found that therapeutic treatment with OLEO protected against infectious colitis, and this was associated with selective increases in several Firmicutes bacteria, including SFB, Clostridium spp., and E. rectale. SFB has been shown to protect against C. rodentium-induced colitis through Th17 immune responses (32) . Although further investigation is required, it is possible that OLEO's enrichment of SFB is modulating Th17 immunity and contributing to the protection against C. rodentium-induced colitis. During infection, the OLEO-treated group was able to maintain total bacterial loads, which were enriched with Firmicutes and depleted of ␥-Proteobacteria, presumably most of which was C. rodentium. In support of this, OLEO treatment resulted in less systemic pathogen load, and OLEO inhibited C. rodentium growth and adherence to intestinal epithelial cells in vitro. While we did not address the mechanism by which OLEO enriched Firmicutes bacteria and simultaneously prevented growth and attachment of C. rodentium, it is feasible that OLEO through 1,8-cineole and borneol interferes with pathogen adherence by blocking or masking the pathogen adherence antigens or host binding sites. Additionally, Firmicutes could be protecting against C. rodentium colonization, which could lead to decreased intestinal injury due to decreased inflammatory responses. Several studies have shown that changes and reduction in the proportion of specific phylogenetic groups of Firmicutes are lower in patients with active IBD than healthy subjects (18, 34, 44, 58, 61, 64) . In support of this, we found that Firmicutes bacteria were closely associated with the gut Intestinal samples from infected mice with or without OLEO treatment were homogenized, filtered onto membranes, and quantified using SYBR Green nucleic acid dye (A) or hybridized with probes specific to Firmicutes, ␥-Proteobacteria, and Bacteroidetes for fluorescent in situ hybridization (FISH) analysis, with Eubacteria used to probe the total number of bacteria in each sample (B). Membranes were examined via fluorescent microscopy to determine total bacteria by counting SYBR Green-positive cells or percentages of bacterial phyla from 5-10 random fields of view. Values are means Ϯ SE. *P Ͻ 0.05 vs. 10 days pi. C: FISH analysis of tissue sections using the Firmicutes-specific probe revealed increased interaction of Firmicutes (red) with intestinal epithelial cells (nuclei stained blue with DAPI) during OLEO treatment in infected mice compared with untreated infected mice. A Eubacterial probe was also costained (green). Original magnification ϫ400. mucosal surface during infection, which could help promote colonization resistance. Some studies have shown that some Firmicutes protect against intestinal inflammation through the synthesis of butyrate, which is an important energy source for epithelial cells and is involved in epithelial cell differentiation and wound healing (56, 61) . Another study found less diversity of butyrate producers, such as C. coccoides groups and E. rectale, in samples from ulcerative colitis patients, corresponding to lower levels of butyryl-CoA transferase, which is responsible for butyrate production (68). While we did not find a significant difference between the major butyrate producers, such as the C. coccoides group, we did find that other butyrate producers, such as E. rectale and other members of Clostridia spp., were enriched with OLEO treatment. Further research is required to determine if OLEO-induced enteric microflora alters butyrate production. In summary, microbial modulation through OLEO treatment has a significant impact on intestinal immune responsiveness to colitis and could well represent the means through which other pharmacological agents affect GI responsiveness, as seen with nonsteroidal anti-inflammatory drug-induced intestinal injury through dysbiosis (70) .
Colitis is associated with neutrophil infiltration into intestinal crypts, attracted via the chemokine MIP-2␣, which can lead to tissue damage as a result of the constant release of inflammatory cytokines, proteases, and reactive oxygen species (47).
Thus, blocking the activity of neutrophils or decreasing the expression of MIP-2␣ is a potential therapeutic strategy against colitis (47) . OLEO-treated infected mice had attenuated responses from proinflammatory mediators, including MIP-2␣, with corresponding decreased neutrophil infiltration. Additionally, macrophages cause tissue damage by promoting proinflammatory and cytotoxic activities due to the release of reactive oxygen and nitrogen species and inflammatory cytokines such as TNF-␣ (39). In OLEO-treated infected mice, macrophage infiltration and responses from proinflammatory mediators, including TNF-␣, IFN-␥, and IL-22, were attenuated. Additionally, OLEO treatment resulted in a significant Fig. 7 . OLEO inhibits C. rodentium adherence and growth in vitro. A: OLEO prevents adherence of C. rodentium to Caco-2 cells. OLEO significantly lowered adherence to Caco-2 cells compared with lavender essential oil (LEO), while 1,8-cineole and borneal, but not camphor, inhibited adherence, similar to OLEO. Caco-2 cells were grown to confluency and inoculated with C. rodentium in the presence of oil extract or purified constituents for 4 h. Adherent C. rodentium-inoculated cells were plated on nutrient agar in serial dilutions, and values were averaged and plotted. B: antimicrobial activity against C. rodentium is seen with OLEO, LEO, and 1,8-cineole; no antimicrobial activity was seen for borneol, camphor, or control mineral oil. C. rodentium was used to inoculate nutrient agar plates, and a filter disk infused with the oil extract or purified constituent was incubated for 18 h at 37°C. Zone of inhibition was measured from disks. Values are means Ϯ SE. *P Ͻ 0.05; **P Ͻ 0.001. reduction in expression of iNOS, which can cause oxidative tissue damage. All these responses have been shown to be important for host defense during C. rodentium infection (3, 25, 59, 60) . These results are significant, inasmuch as therapies for IBD that aim to inhibit the action of proinflammatory cytokines can reduce disease severity and/or disease progression (17) . Finally, regulatory T cells play an important role in suppressing intestinal inflammatory responses, and it has been shown that these cells suppress colitis and may be an efficacious therapy for IBD (51) . While C. rodentium infection resulted in the loss of regulatory T cell populations, OLEO was able to maintain these populations during infection. Overall, OLEO treatment decreases damaging proinflammatory responses and promotes regulatory responses important for balanced GI immunity.
In conclusion, the large decrease in mortality in the susceptible mice, as well as the significant decrease in morbidity, cecal tissue damage, proinflammatory cytokine production, and immune cell infiltration in the more resistant mice, strongly supports the notion that OLEO protects against infectious colitis. Protection was associated with modulation of the enteric microbiota, with selective increases in Firmicutes and antimicrobial and antiadherence activities against C. rodentium. This corresponded with decreases in inflammatory and injurious host defensive responses and maintenance of regulatory T cells important for balancing GI immunity. Our results reveal that OLEO has potential therapeutic effects against acute colitis through the microbial-immunity nexus. As demonstrated by these results and others (70) , ingested drugs can modulate the enteric microflora, and future studies should examine how other drugs could affect selective modulation of certain microbial populations that could be detrimental or beneficial.
